Antioxidants for Male Fertility: What the Expert Recommendations Actually Say (and Don’t)

Evidence-based · Written by Dr. Lejla Fazlicic, D.Ac, L.Ac · All key claims cited to peer-reviewed research · Last reviewed October 2026

The short answer: Antioxidants for male fertility sit in an uncomfortable gap between practice and proof: in a global survey, 76.9% of 436 fertility experts said they prescribe them empirically, usually for 3–6 months, yet the best randomized trial to date (MOXI) found no improvement in semen parameters, sperm DNA integrity, or live birth. The Cochrane review calls the supporting evidence low to very low certainty. Food-based antioxidants — the approach with the least hype — actually have a randomized trial showing improved sperm quality and lower DNA fragmentation.

If you have searched for antioxidants for male fertility, you have probably seen two completely different stories: supplement companies promising transformed sperm in 90 days, and skeptics saying it is all snake oil. Neither story is honest. The honest version is more interesting — and more useful — because it tells you what fertility specialists actually do, what the best trial actually found, and where the real leverage sits. That is what this article walks through, pillar by pillar, with every claim linked to the research it came from.

Why would antioxidants help sperm in the first place?

The idea is not marketing invention — it starts from real biology. Sperm cells are unusually vulnerable to oxidative stress, the state where reactive oxygen species (ROS) outrun the body's ability to neutralize them. A major review in Nature Reviews Urology by Bisht and colleagues describes why: sperm carry very limited antioxidant defenses of their own, their membranes are rich in easily oxidized polyunsaturated fats, and — critically — they have almost no capacity to repair DNA damage once it occurs [1].

Oxidative stress is considered a leading contributor to sperm DNA fragmentation — breaks in the genetic material sperm carry — which has been associated with lower fertilization rates, poorer embryo development, and pregnancy loss. The same review makes a point I find myself repeating in clinic: most of the drivers of seminal oxidative stress are lifestyle-related and modifiable — heat, smoking, alcohol, poor sleep, excess weight, sedentary habits, environmental exposures [1].

So the logic chain seems obvious: oxidative stress damages sperm DNA → antioxidants neutralize oxidative stress → therefore antioxidant pills should protect sperm. It is a plausible chain. Plausible mechanisms are where good science starts. But a plausible mechanism is not the same thing as a proven treatment, and holding that distinction is the whole point of this article. If sperm DNA damage is the issue you are trying to solve, it helps to first understand what a sperm DNA fragmentation test measures, what it costs, and how to read the results — because you cannot track what you have not measured.

What do the expert recommendations actually say?

Here is the part most articles skip: what fertility specialists actually do in practice, as opposed to what any single trial says.

In 2023, the Global Andrology Forum published a global consensus survey on managing elevated sperm DNA fragmentation, drawing on responses from 436 experts across 55 countries [2]. Three findings matter most for our purposes:

• Empiric antioxidants are extremely common. 76.9% of surveyed experts said they prescribe antioxidants empirically — meaning without first confirming, with a lab test, that the individual man has elevated oxidative stress.
• The typical course is 3–6 months. 39.3% recommend 4–6 months and 38.1% recommend about 3 months — a window that makes biological sense, because a full cycle of sperm production and transit takes roughly two and a half to three months.
• Lifestyle comes first, and ART is not the opening move. 79.1% recommend lifestyle modification for men with elevated DNA fragmentation, and the consensus position is that assisted reproductive technology (IVF/ICSI) should not be the initial approach — conservative management gets a fair trial first, with escalation considered after about six months if things have not improved [2].

Notice the ordering. Even among experts who reach for antioxidant prescriptions, supplements are an adjunct to lifestyle change, not a substitute for it. That ordering matches how I work with couples: daily habits first, timed to the 74-day sperm production cycle, as in daily habits linked to sperm DNA health.

One more data point belongs here, because it is the closest thing to an official position in the United States. The AUA/ASRM male infertility guideline — the joint guideline of American urologists and reproductive medicine specialists — tells clinicians to counsel patients that the benefits of supplements such as antioxidants are of questionable clinical utility, and that existing data are inadequate to recommend any specific agent [3]. Read that again: the formal guideline does not endorse a single named antioxidant product. Whatever a supplement label implies, no major urology or fertility society stands behind it.

What did the MOXI trial find?

This is the centerpiece, and I am going to present it plainly, because almost nobody selling antioxidants will.

The Males, Antioxidants, and Infertility (MOXI) trial, published by Steiner and colleagues in Fertility and Sterility in 2020, is the most rigorous test of antioxidant supplementation for male-factor infertility we have: a randomized, double-blind, placebo-controlled trial run across the NIH-funded Reproductive Medicine Network [4]. Researchers randomized 174 men with abnormal semen parameters (their partners had normal fertility workups) to either placebo or a daily antioxidant formulation that looks a lot like the popular "male fertility blends" sold online — vitamin C, vitamin E, selenium, l-carnitine, zinc, folic acid, and lycopene — for a minimum of three months and up to six.

The results:

• Semen parameters: no meaningful improvement. At three months, there were no statistically significant differences between the antioxidant and placebo groups in sperm concentration, motility, or morphology — including in the subgroups of men who started with low counts, poor motility, or abnormal morphology [4].
• Sperm DNA fragmentation: no significant difference. The antioxidant blend did not meaningfully improve DNA integrity compared with placebo [4].
• Live birth: no benefit. In the couples followed for six months, live birth occurred in 15% of the antioxidant group versus 24% of the placebo group — numerically lower with antioxidants, though the difference was not statistically significant (P = .14) [4].

The trial was stopped early after this planned interim analysis, because continuing to the full second phase was judged futile — the data gave no signal that antioxidants were going to outperform placebo. The authors' conclusion was blunt: in this population, antioxidants did not improve semen parameters or DNA integrity, and did not improve pregnancy outcomes [4].

Two honest caveats, because honesty cuts both ways. First, MOXI was designed as a phase 2 trial — 174 men is enough to detect changes in semen parameters, but not enough to give a definitive answer on live birth. Second, it tested one specific combination at one set of doses; it cannot rule out that a different agent, dose, or population (for example, only men with lab-confirmed high oxidative stress) might respond differently. But those caveats do not rescue the marketing claims. If you were told that a multi-antioxidant blend reliably improves sperm counts in three months, the best available randomized evidence says otherwise. And if you have a normal semen analysis yet cycles keep failing, the issue may not be anything a pill addresses — we walk through that scenario in why a normal semen analysis can still hide a DNA fragmentation problem.

What does the Cochrane review say?

A single trial, however well run, is one data point. Cochrane reviews exist to weigh all of them together, and the Cochrane review of antioxidants for male subfertility — most recently updated by de Ligny and colleagues in 2022 — pooled 90 randomized trials involving 10,303 subfertile men [5].

On its face, the pooled result sounds encouraging: antioxidants may increase live birth (from roughly 16 per 100 couples with placebo to somewhere between 17 and 27 per 100) and may increase clinical pregnancy rates. But the authors attach the qualifiers that matter:

• The evidence for live birth was rated very low certainty, and for clinical pregnancy low certainty — the lowest confidence grades Cochrane assigns [5].
• Only 12 of the 90 studies reported live birth at all, and the included trials were plagued by small sample sizes, incomplete outcome reporting, and unclear methods [5].
• When the reviewers removed studies at high risk of bias in a sensitivity analysis, the live birth benefit disappeared [5].
• On the safety side: antioxidants were associated with a modest increase in mild gastrointestinal upset, and no difference in miscarriage was found in the studies that reported it [5].

Translation into plain language: when you average many small, mostly lower-quality trials, a possible benefit appears — and when you restrict the analysis to the more trustworthy trials, it fades. That pattern (small biased studies positive, rigorous studies null) is one of the most familiar shapes in nutrition-supplement research, and MOXI fits it exactly.

Do antioxidants for male fertility actually work, then?

So how do we hold both facts at once — that three-quarters of world experts prescribe antioxidants, and that the best trial found nothing? I do not think the experts are foolish, and I do not think the trial is wrong. They are answering slightly different questions.

Experts prescribing a 3–6 month antioxidant course are making a pragmatic bet: oxidative stress is a genuine, well-documented mechanism of sperm damage [1]; a standard-dose antioxidant course is inexpensive and low-risk (the main documented side effect being mild stomach upset [5]); and the alternative escalation — IVF with ICSI — is expensive, invasive, and carries its own trade-offs. In that frame, "unproven but cheap, safe, and mechanistically plausible" can be a defensible clinical judgment, especially alongside lifestyle change. That is the charitable reading of the 76.9%, and I think it is largely the correct one [2].

What that judgment does not support is the version sold to consumers: that a proprietary blend will fix sperm quality on its own. And there is a deeper problem with the pill-first framing — the whole-food comparison makes it look worse, not better.

In the FERTINUTS randomized trial, Salas-Huetos and colleagues took 119 healthy young men eating a Western-style diet and randomized half of them to add 60 grams of mixed nuts (walnuts, almonds, and hazelnuts) daily for 14 weeks, changing nothing else [6]. The nut group improved significantly in total sperm count, vitality, motility, and morphology — and, notably, showed a significant reduction in sperm DNA fragmentation, the very outcome the MOXI supplement blend failed to move [4,6]. One food-based trial does not settle anything either; FERTINUTS studied healthy men, not men with infertility, and nuts deliver far more than antioxidants — omega-3 fats, arginine, fiber, zinc, selenium, folate, polyphenols, all in one package. But that is rather the point. The intervention with a positive randomized result on sperm DNA was a whole food, not an extract. Food-first is not a wellness slogan here; it is where the better evidence sits.

Which foods deliver the same antioxidants?

Every nutrient in the MOXI blend — and in virtually every "fertility blend" on the market — is available on a dinner plate, packaged with the cofactors and fiber that pills strip away. The table below covers the antioxidants (and antioxidant-adjacent nutrients) most often discussed for male fertility, where to find them in food, and an honest one-line read of the evidence [4,5,6,7,8,9].

Two practical notes on using this table. First, the pattern that keeps emerging in dietary research is that overall eating patterns — vegetables, fruit, nuts, seeds, fish, legumes, whole grains, less processed meat and added sugar — track with better semen quality more consistently than any single nutrient does. That is the architecture behind our 74-day male fertility diet, which times these foods to a full sperm production cycle. Second, food delivers antioxidants at physiological doses. You cannot realistically megadose vitamin E with sunflower seeds — and as the next section explains, that constraint is a feature, not a limitation.

When should you ask a clinician about supplements — and what are the red flags?

I am food-first, not supplement-never. There are situations where a conversation with your urologist, reproductive endocrinologist, or physician about supplementation is entirely reasonable:

• Documented deficiency. If bloodwork shows you are actually low in zinc, vitamin D, or another nutrient, correcting a deficiency is standard medicine — and different from megadosing an already-adequate nutrient.
• Elevated sperm DNA fragmentation on testing. If an SDF test comes back high, you are in exactly the population the Global Andrology Forum survey describes — where many specialists will discuss a time-limited 3–6 month antioxidant course alongside lifestyle change [2]. Let your clinician choose the agent and dose; that is their call, not a label's.
• Restricted diets. Vegans, men with absorption issues, or men post-bariatric-surgery may genuinely need targeted supplementation a clinician can tailor.
• A defined timeline before IVF/ICSI. If you are 3–4 months out from a retrieval cycle, ask your care team what, if anything, they want added — and what they want stopped.

And here are the red flags I want you to walk away from:

• Megadosing. More is not better. Physiological levels of reactive oxygen species are required for sperm capacitation and fertilization — the final maturation steps that let a sperm actually penetrate an egg. Researchers call the downside of over-suppressing ROS the "antioxidant paradox" or reductive stress: flood the system with high-dose antioxidants and you can, in principle, impair the very function you are trying to protect [7,10]. Selenium adds a second hazard: its window between adequate and toxic is narrow [9].
• "Fertility blend" marketing. Proprietary blends that hide doses, testimonials in place of trials, "clinically proven" claims that cite mouse studies or the very low-certainty trials Cochrane flagged [5] — these are marketing constructions. Remember: the MOXI formulation was essentially a well-designed fertility blend, and it did not beat placebo [4].
• Supplements as a license to skip the hard part. The experts who prescribe antioxidants put lifestyle first [2]. A capsule cannot outwork nightly alcohol, a hot tub habit, smoking, or chronic sleep debt. Movement matters too — resistance and aerobic training have their own evidence for semen quality, which we cover in exercise and sperm quality across the 74-day cycle.
• No follow-up. If a supplement is suggested with no plan to check whether it helped, ask his urologist how and when they'll measure it.

What we do with this

Here is the honest bottom line I give the couples I work with. Oxidative stress is real, and sperm are genuinely vulnerable to it [1]. The pill-based fix is unproven — tested fairly, the best trial found nothing [4], and the wider literature is too weak to lean on [5]. The whole-food version of the same idea has a positive randomized trial behind it [6], costs less, and carries none of the megadose risk. So the habits I work on with couples are food, sleep, movement, avoiding heat and cutting back on substances, timed to the ~74-day sperm production cycle. Testing and any supplement are his urologist's call.

If you want to know whether your daily habits cover the basics linked to sperm health, or you're staring at a supplement shelf wondering what's real, start here: Get the free guide → or Try Pocket Coach for him free for 7 days →.

References

1. Bisht S, Faiq M, Tolahunase M, Dada R. Oxidative stress and male infertility. Nature Reviews Urology. 2017;14(8):470–485. https://www.nature.com/articles/nrurol.2017.69
2. Farkouh A, Agarwal A, Hamoda TAA, et al. Controversy and Consensus on the Management of Elevated Sperm DNA Fragmentation in Male Infertility: A Global Survey, Current Guidelines, and Expert Recommendations. The World Journal of Men's Health. 2023;41(4):809–847. https://pmc.ncbi.nlm.nih.gov/articles/PMC10523126/
3. American Urological Association / American Society for Reproductive Medicine. Diagnosis and Treatment of Infertility in Men: AUA/ASRM Guideline (2020; amended 2024). https://www.auanet.org/guidelines-and-quality/guidelines/male-infertility
4. Steiner AZ, Hansen KR, Barnhart KT, et al. The effect of antioxidants on male factor infertility: the Males, Antioxidants, and Infertility (MOXI) randomized clinical trial. Fertility and Sterility. 2020;113(3):552–560.e3. https://www.fertstert.org/article/S0015-0282(19)32547-6/fulltext
5. de Ligny W, Smits RM, Mackenzie-Proctor R, et al. Antioxidants for male subfertility. Cochrane Database of Systematic Reviews. 2022;5:CD007411. https://www.cochrane.org/evidence/CD007411_antioxidants-male-subfertility
6. Salas-Huetos A, Moraleda R, Giardina S, et al. Effect of nut consumption on semen quality and functionality in healthy men consuming a Western-style diet: a randomized controlled trial (FERTINUTS). The American Journal of Clinical Nutrition. 2018;108(5):953–962. https://ajcn.nutrition.org/article/S0002-9165(22)03015-5/fulltext
7. Dutta S, Sengupta P, Roychoudhury S, et al. Antioxidant Paradox in Male Infertility: 'A Blind Eye' on Inflammation. Antioxidants. 2022;11(1):167. https://www.mdpi.com/2076-3921/11/1/167
8. National Institutes of Health, Office of Dietary Supplements. Zinc — Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional/
9. National Institutes of Health, Office of Dietary Supplements. Selenium — Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Selenium-HealthProfessional/
10. Henkel R, Sandhu IS, Agarwal A. The excessive use of antioxidant therapy: A possible cause of male infertility? Andrologia. 2019;51(1):e13162. https://onlinelibrary.wiley.com/doi/abs/10.1111/and.13162

Frequently Asked Questions

How long would antioxidants need to work, if they work at all?

Sperm take roughly 74 days to develop and mature, which is why fertility experts who prescribe antioxidants typically recommend a 3–6 month course before retesting — anything shorter cannot show up in a semen analysis. That said, the best randomized trial (MOXI) used exactly that window and still found no improvement over placebo, so a fair trial period is no guarantee of benefit. If he does try one, ask his urologist about a follow-up test so you're measuring rather than guessing.

Should I stop my fertility supplement because of the MOXI trial?

Not on your own, and not because of one article — that decision belongs with the clinician who knows your labs and history. MOXI found no benefit from a common multi-antioxidant blend, and standard-dose courses appear low-risk, so this is usually not an emergency either way. It is, however, a very good reason to ask your doctor two questions: what specific outcome is this supplement supposed to change, and when will we retest to see if it did?

Can I get enough antioxidants from food alone?

For most men eating a varied diet, yes — vitamin C, vitamin E, zinc, selenium, folate, and CoQ10 are all obtainable from foods like citrus, nuts, seeds, seafood, eggs, legumes, and leafy greens, and the one randomized trial that improved sperm DNA fragmentation used whole foods (60 g of mixed nuts daily), not capsules. Exceptions exist: documented deficiencies, restricted diets, and absorption problems can justify targeted supplementation under clinical guidance. Food-first is the default; supplements are the exception you discuss with your care team.

This article is general education, not medical advice; decisions about supplements, testing, and treatment belong with your own clinician.